PRAME - Wikipedia PRAME (preferentially expressed antigen of melanoma) is a protein that in humans is encoded by the PRAME gene [3][4][5] Five alternatively spliced transcript variants encoding the same protein have been observed for this gene
Pathology Outlines - PRAME PRAME (preferentially expressed antigen in melanoma) is a cancer testis antigen expressed by melanoma and other malignant neoplasms with expression in normal tissue largely restricted to testis
What Does a Positive PRAME Test Mean for Melanoma? PRAME testing is ordered when a pathologist examines a biopsied skin lesion difficult to classify based on traditional microscopic features alone The test provides molecular confirmation that helps distinguish between a benign lesion, like a nevus, and a malignant melanoma
PRAME: Definition – MyPathologyReport PRAME stands for “preferentially expressed antigen in melanoma ” It is a special type of protein called a cancer-testis antigen This means that PRAME is usually found in cancer cells and normal cells within the testis, but rarely in other normal tissues of the body
Autologous T cell therapy for PRAME - Nature This work clinically validates PRAME as a target for treatment of multiple solid cancers and points to a new benchmark for a high rate of durable response in patients with last-line melanoma
PRAME: What Is It and Should My Lab Be Using It? PRAME has low to no expression in regular tissue (except for a few such as testis and ovaries) but high expression in malignant cells, particularly in primary and metastatic melanomas, making it a valuable marker for melanoma diagnosis, though it has also been used in other types of cancer diagnosis including leukemia, lymphoma, breast cancer
The Role of PRAME in Malignant Melanoma: From Biomarker to Therapeutic . . . PRAME emerges as a promising biomarker and therapeutic target in malignant melanoma, offering avenues for improved diagnosis, prognostication, and treatment Its pivotal roles in driving disease progression underscore its significance in malignant melanoma pathogenesis